Financial Ratios

RAINBOW CHILDREN'S MEDICARE LTD.

NSE : RAINBOWBSE : 543524ISIN CODE : INE961O01016Industry : Hospital & Healthcare ServicesHouse : Private
BSE1343.8528.05 (+2.13 %)
PREV CLOSE ( ) 1315.80
OPEN PRICE ( ) 1323.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9020
TODAY'S LOW / HIGH ( )1322.15 1352.00
52 WK LOW / HIGH ( )761.2 1488.45
NSE1343.5527.35 (+2.08 %)
PREV CLOSE( ) 1316.20
OPEN PRICE ( ) 1330.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1343.55 (94)
VOLUME 77137
TODAY'S LOW / HIGH( ) 1322.05 1353.45
52 WK LOW / HIGH ( )756.8 1487.65
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)20.2815.1311.2416.1213.51
   CEPS(Rs)28.5323.3113.0215.0710.61
   DPS(Rs)3.002.000.002.001.00
   Book NAV/Share(Rs)107.2366.49105.7894.3391.61
   Tax Rate(%)24.5425.0125.0135.0724.82
Margin Ratios
   Core EBITDA Margin(%)34.5632.3126.9630.0220.72
   EBIT Margin(%)29.4426.2317.8622.4015.65
   Pre Tax Margin(%)24.4920.5210.7215.7114.61
   PAT Margin (%)18.4815.398.0410.2010.99
   Cash Profit Margin (%)26.0023.7219.0919.5417.62
Performance Ratios
   ROA(%)13.6912.154.588.6111.92
   ROE(%)24.0326.1011.2317.3415.88
   ROCE(%)37.1740.4921.8832.9420.31
   Asset Turnover(x)0.740.790.570.841.09
   Sales/Fixed Asset(x)0.950.910.701.141.44
   Working Capital/Sales(x)3.305.686.096.918.36
Efficiency Ratios
   Fixed Capital/Sales(x)1.061.101.420.880.70
   Receivable days16.2417.1224.3517.0914.78
   Inventory Days5.174.577.105.664.35
   Payable days169.51106.59174.66136.12131.68
Valuation Parameters
   PER(x)36.000.000.000.000.00
   PCE(x)25.590.000.000.000.00
   Price/Book(x)6.810.000.000.000.00
   Yield(%)0.41
   EV/Net Sales(x)6.62-0.030.030.020.07
   EV/Core EBITDA(x)17.72-0.090.090.070.30
   EV/EBIT(x)22.49-0.130.150.100.42
   EV/CE(x)4.26-0.020.020.010.06
   M Cap / Sales6.650.000.000.000.00
Growth Ratio
   Net Sales Growth(%)20.4850.47-11.6028.0635.08
   Core EBITDA Growth(%)30.2779.90-19.4882.3452.50
   EBIT Growth(%)35.20121.05-29.5183.2565.76
   PAT Growth(%)44.70187.96-30.2818.8763.46
   EPS Growth(%)34.0834.59-30.2819.3365.44
Financial Stability Ratios
   Total Debt/Equity(x)0.000.060.100.130.12
   Current Ratio(x)3.512.391.871.601.77
   Quick Ratio(x)3.382.271.791.521.69
   Interest Cover(x)5.954.592.503.3515.09
   Total Debt/Mcap(x)0.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.